Jim Simons's position in Vertex Pharmaceuticals is currently worth $679 Million. That's 0.88% of their equity portfolio (8th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2013. Since then Jim Simons bought shares eighteen more times and sold shares on fourteen occasions. The stake costed the investor $373 Million, netting the investor a gain of 82% so far.